AeroLeads people directory · profile

Doug Lytle, Phd, Mba, Jd Email & Phone Number

Sr Director, Business Development, Clinical Pharmacology Specialist at Labcorp Drug Development
Location: Bethlehem, Pennsylvania, United States 9 work roles 4 schools
LinkedIn matched
✓ Verified May 2026 3 data sources Profile completeness 100%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Sr Director, Business Development, Clinical Pharmacology Specialist
Location
Bethlehem, Pennsylvania, United States
Company size

Who is Doug Lytle, Phd, Mba, Jd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Doug Lytle, Phd, Mba, Jd is listed as Sr Director, Business Development, Clinical Pharmacology Specialist at Labcorp Drug Development, a company with 40272 employees, based in Bethlehem, Pennsylvania, United States. AeroLeads shows a matched LinkedIn profile for Doug Lytle, Phd, Mba, Jd.

Doug Lytle, Phd, Mba, Jd previously worked as Sr. Director, Clinical Pharmacology Services at Fortrea and Sr Director, Clinical Pharmacology Services at Labcorp Drug Development. Doug Lytle, Phd, Mba, Jd holds Doctor Of Law - Jd from Widener University Schools Of Law.

Company email context

Email format at Labcorp Drug Development

This section adds company-level context without repeating Doug Lytle, Phd, Mba, Jd's masked contact details.

Labcorp Drug Development

Review company-level records connected to Doug Lytle, Phd, Mba, Jd before choosing the right outreach path.

Profile bio

About Doug Lytle, Phd, Mba, Jd

My PhD (pharmacology), combined with 25 years of clinical trial experience, provides extensive understanding of clinical trials across all therapeutic areas - with concentrations in Oncology (~35%) and CNS (~20%). My MBA and JD equip me to handle strategy, persuasion, and regulatory compliance challenges. I have developed a subspecialty of running clinical trials more efficiently using best in breed technologies and services. For the past 10+ years, I have also consulted with expert networks, providing weekly advice to investment firms regarding clinical research and therapeutic areas. Across 25 years of expereince, I have advised on 100+ Phase 2 and 3 clinical trial protocols regarding site and country strategy, optimization of study design, and increased reliability of subjective outcomes. I thrive in cross-functional teams, identifying and resolving issues proactively, with a focus on improving efficiency and accelerating clinical trial timelines.Specialties: Strategic planning for clinical programs and clinical studies, financial management of clinical studies and departments, review of clinical protocols for study and enrollment challenges. Forecasting revenue and expenses, negotiation of contracts and budgets. Multiple therapeutic areas including Oncology, CNS, cardiovascular/metabolics as well as vaccines and mAbs. Honed oral presentation, verbal and written communication skills. Information technology savvy with complete suite of computer skills (Excel, Power Point, MS Project); Continuous improvement of time management, productivity, and leadership skills; Broad knowledge of protocol and study design with ability to address key challenges for each study

Listed skills include Cro, Clinical Development, Oncology, Clinical Trials, and 32 others.

Current workplace

Doug Lytle, Phd, Mba, Jd's current company

Company context helps verify the profile and gives searchers a useful next step.

Labcorp Drug Development
Labcorp Drug Development
Sr Director, Business Development, Clinical Pharmacology Specialist
Bethlehem, PA, US
Website
Employees
40272
AeroLeads page
9 roles

Doug Lytle, Phd, Mba, Jd work experience

A career timeline built from the work history available for this profile.

Sr. Director, Clinical Pharmacology Services

Durham, North Carolina, US

NOT a new position - I am continuing my role and responsibilities which started at Covance, Labcorp Drug Development and now Fortrea. Fortrea is a carve out of Covance/Labcorp CRO services that are focused on executing Phase 1-4 clinical trials with excellence.

Jun 2023 - Nov 2024

Sr Director, Clinical Pharmacology Services

Burlington, North Carolina, US

  • Advised on strategies for 100+ FIH Phase 1 and clinical pharmacology studies;
  • Trained and consulted on Diversity Action Plans for clinical studies;
  • Reviewed and revised clinical pharmacology protocol designs and timelines;
  • Developed and reviewed documents for IND, IB, protocols, and other regulatory submissions;
  • Collaborated with nonclinical teams to transition from IND-enabling to Phase I studies;
  • Worked on studies using small molecules, proteins, and large molecules in all therapeutic areas;
Mar 2017 - Jun 2023

Executive Director, Clinical Assessment Technologies

Research Triangle Park, NC, US

  • I serve as a leader for the Clinical Assessment Technologies (CAT) department supervising a team of 16 project management and clinical team members. CAT provides specialized compliance of clinical trial sites to.
  • Developed and deployed innovative patient eligibility review process, going beyond traditional in/exclusion criteria* Produced ten (10) detailed and refined process maps for all departmental services* Updated all (3).
Jun 2015 - Dec 2016

Sr Director, Business Development

Epharmasolutions (Acquired By) Wirb Copernicus
  • Consult with clinical study teams and Sr Leadership positions within the pharmaceutical industry to deploy the best services and technologies that optimize site start up, patient recruitment/engagement, and overall.
  • Worked directly with 15 clinical teams post award to implement specific areas improvements in clinical studies
  • Consulted with ~80 project teams across 35+ pharma companies to address specific issues with clinical studies
  • Responsible to develop and deploy innovative site startup and global patient engagement solutions
  • Developed specific expertise as a site compliance (GCP, SAE, etc.) and CNS Rater Reliability Specialist
  • Significant focus on making oncology studies more efficient during startup and enrollment periods
Jan 2013 - May 2015

Director, Business Development

Zug, CH

  • A Senior Leadership role in a Clinical Research Organization (CRO) serving the pharmaceutical industry within the clinical development function. I delivered proposals, budgets and strategies, focusing on medical and.
  • Consulted on proposals, documentation and strategies, focusing on medical and technical aspects of protocols
  • Served as a medical leader at bid defense meetings and in proposal development process
  • Provided strategic insight into key aspects and protocol specific challenges of clinical development
  • Concentrated in oncology (three pancreatic protocols, bladder and AML, CLL, others)
Nov 2009 - Dec 2012

Sr Director, Strategic Business Development

Slough, Berkshire SL1 4AA, GB

  • Brought in long term, global clinical research partnerships with budget values over $100 million in 2008-2009
  • Developed new top-five pharma account which became one of top three clients in 2006, 2007 and 2008
  • Strategic lead for Vaccine and Biological sales initiatives; developed oncology and traditional vaccine clients
  • Managed and mentored new and junior team members – documented and delivered training in GCP and SOPs
  • Lead various key partnerships strategies, negotiations, and strategic plans to gain new customers
Nov 2004 - Oct 2009

Director, Business Development

Dublin, IE

  • Immediate impact by winning over $4 million of work across two clients within first two months of start
  • Recovered relationships with two key customers after poor project management and communication issues
  • Worked with groups in Medical Affairs, Clinical Operations, Project Management and Clinical Development
May 2004 - Nov 2004

Director Of Operations And Finance

US

  • Started in finance department, then moved to general clinical management and then managed change order development and negotiation for entire company.
  • Head of Change Order Development and negotiated $10 million of budgets in 2001 and 2002
  • Clinical operations management remits assigning and accounting for CRA responsibilities
  • Lead company-wide monthly clinical budgets, operations and project management meetings
  • Forecasted budgets and revenues and identified variances from project and departmental budgets
  • Managed staff of 5+ people in two separate roles (accounting, finance and operations)
May 1999 - May 2004
Team & coworkers

Colleagues at Labcorp Drug Development

Other employees you can reach at labcorp.com. View company contacts for 40272 employees →

4 education records

Doug Lytle, Phd, Mba, Jd education

Doctor Of Law - Jd

Widener University Schools Of Law

Mba, Finance, General

Cornell Johnson Graduate School Of Management

Phd, Pharmacology

Unt Health Science Center

Bs, Neuroscience

Texas Christian University
FAQ

Frequently asked questions about Doug Lytle, Phd, Mba, Jd

Quick answers generated from the profile data available on this page.

What company does Doug Lytle, Phd, Mba, Jd work for?

Doug Lytle, Phd, Mba, Jd works for Labcorp Drug Development.

What is Doug Lytle, Phd, Mba, Jd's role at Labcorp Drug Development?

Doug Lytle, Phd, Mba, Jd is listed as Sr Director, Business Development, Clinical Pharmacology Specialist at Labcorp Drug Development.

Where is Doug Lytle, Phd, Mba, Jd based?

Doug Lytle, Phd, Mba, Jd is based in Bethlehem, Pennsylvania, United States while working with Labcorp Drug Development.

What companies has Doug Lytle, Phd, Mba, Jd worked for?

Doug Lytle, Phd, Mba, Jd has worked for Labcorp Drug Development, Fortrea, Worldwide Clinical Trials, Epharmasolutions (Acquired By) Wirb Copernicus, and Psi Cro.

Who are Doug Lytle, Phd, Mba, Jd's colleagues at Labcorp Drug Development?

Doug Lytle, Phd, Mba, Jd's colleagues at Labcorp Drug Development include Tanesha Reed, Jennifer Buenteo, Bruce Dickie, Shane Baker, and Deanna Hutchinson.

How can I contact Doug Lytle, Phd, Mba, Jd?

You can use AeroLeads to view verified contact signals for Doug Lytle, Phd, Mba, Jd at Labcorp Drug Development, including work email, phone, and LinkedIn data when available.

What schools did Doug Lytle, Phd, Mba, Jd attend?

Doug Lytle, Phd, Mba, Jd holds Doctor Of Law - Jd from Widener University Schools Of Law.

What skills is Doug Lytle, Phd, Mba, Jd known for?

Doug Lytle, Phd, Mba, Jd is listed with skills including Cro, Clinical Development, Oncology, Clinical Trials, Clinical Research, Ctms, Drug Development, and Gcp.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.